Lexeo Therapeutics, Inc. Common Stock
LXEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $175 | $115 | $218 |
| - Cash | $41 | $35 | $29 | $35 |
| + Debt | $6 | $9 | $9 | $10 |
| Enterprise Value | – | $149 | $95 | $193 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$20 | -$26 | -$32 | -$25 |
| % Margin | – | – | – | – |
| Net Income | -$20 | -$26 | -$33 | -$26 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.33 | -0.6 | -0.99 | -0.78 |
| % Growth | 45% | 39.4% | -26.9% | – |
| Operating Cash Flow | -$30 | -$27 | -$22 | -$28 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$30 | -$27 | -$22 | -$28 |